Keros Therapeutics, Inc.
Disclosed SEC business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Keros Therapeutics, Inc. (ticker KROS, CIK 0001664710) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 0 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-25T01:23:05.778712+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing index · retrieved 2026-10-19T18:42:53.926392+00:00
- SEC EDGAR · issuer filing index
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.